Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 26, 2021 | Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 | JIAXING, China and BURLINGAME, Calif., Oct. 26, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been approved by the C... |
| Aug 17, 2021 | Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China | JIAXING, China and BURLINGAME, Calif., Aug. 17, 2021 /PRNewswire/ -- Angel Pharmaceuticals Ltd. ("Angel Pharma") today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA... |
| Angel pharmaceutical |
Reviews 0
FAQ about Angel pharmaceutical
What has the press written about Angel pharmaceutical?
Parsers VC has collected 4 articles mentioning Angel pharmaceutical, among them “Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818” (Oct 26, 2021) and “Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China” (Aug 17, 2021).
Is Angel pharmaceutical still active?
Yes, Angel pharmaceutical is active; its latest activity on Parsers VC dates from Sep 27, 2022.